Effectiveness of carnosine on disturbed electrolytes homeostasis induced by cisplatin

African Journal of Biotechnology

Volumn 10, Issue 37, 2011, Pages 7286-7293

  Noori, Shafaq ^a   Mahboob, Tabassum ^a  

^a UNIVERSITY OF KARACHI   (Pakistan)

Author keywords

Carnosine; Cisplatin; Electrolytes; Na + K + ATPase

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CALCIUM ION; CARNOSINE; MAGNESIUM ION; POTASSIUM ION; SODIUM ION;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIOXIDANT ACTIVITY; ARTICLE; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; ELECTROLYTE DISTURBANCE; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; HOMEOSTASIS; MAGNESIUM BLOOD LEVEL; MALE; NONHUMAN; POTASSIUM BLOOD LEVEL; RAT; SODIUM BLOOD LEVEL;

RATTUS NORVEGICUS;

EID: 79960803462     PISSN: 16845315     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Arany I, Safirstein RL (2003). Cisplatin Nephrotoxicity. Seminars Nephrol. 23: 460-464.
2. Binet A, Volfin P (1977). Effect of an anti-tumor platinum complex, Pt(II) diamino-toluene on mitochondria. Biochem. Biophys. Acta. 461: p. 182.
3. Blachley JD, Hill JB (1981). Renal and electrolytes disturbances associated with Cisplatin. Ann. Int. Med. 95(5): 628-632.
4. Bogin E, Marom M, Levi Y (1994). Changes in serum, liver and kidneys of CP-treated rats; effects of antioxidants. Eur. J. Clin. Chem. Biochem. 32: 843-851
5. Cabezos PA, Vera G, Martín-Fontelles MI, Fernandez-Pujol R, Abalo R (2010). Cisplatin-induced gastrointestinal dysmotility is aggravated after chronic administration in the rat. Comparison with pica. Neurogastroenterol. Motil. 22(7): 797- 805.
6. +- ATPase activity, metabolic control and neuropathy in IDDM patients. Diabetes Care, 19(6): 564-568.
7. Goren MP (2003). Cisplatin nephrotoxicity affects magnesium and calcium metabolism. Med. Pediatr. Oncol. 41(3): 186-189.
8. Gulshanara B, Adam C, Michael L (2005). Physiological Role of Carnosine in Contracting Muscle. Int. J. Sport Nutri. Exercise Metabolism, 15: 493-514.
9. Hallry H, Sky Peck HH (1967). Method for the estimation of serum magnesium. Clin. Chem. 10: p. 391.
10. Hipkiss AR, Chana H (1998). Carnosine protects proteins against methyl glyoxal mediated modifications. Biochem. Biophys. Res. Commun. 248(1): 28-32.
11. Kuriakose GC, Kurup MG (2008). Evaluation of renoprotective effect of Aphanizomenon flos-aquae on CP-induced renal dysfunction in rats. Ren Fail. 30(7): 717-725.
12. Lajer H, Kristensen M, Hansen HH, Nielsen S, Franiaer J, Ostergaard LF, Christensen S, Daugaard G, Jonassen TE (2005). Magnesium depletion enhances CP-induced nephrotoxicity. Cancer Chemother Pharmacol. 56: 535-542.
13. Lajer H, Bundgaard H, Secher NH, Hansen HH, Kjeldsen K, Daugaard G (2003). Severe intracellular magnesium and potassium depletion in patients after treatment with CP. Br. J. Cancer, 89: 1633-1637.
14. Ray S, Roy K, Sengupta C (2006). CP-induced lipid peroxidation and its inhibition with Ascorbic acid. Indian J. Pharmaceut. Sci. 68: 199-204.
15. Savory J, Pu PH, Sunderman FW (1968). A Biuret method for determination of protein. Clin. Chem. 14: 1168-1171.
16. Schrier RW, Wang W, Poole B, Mitra A (2004). Acute renal failure:definitions, diagnosis, pathogenesis, and therapy. J. Clin. Invest. 114: 5-14.
17. Shafaq N, Tabassum M (2010). Antioxidant effect of Carnosine pretreatment on CP - induced renal oxidative stress in rats. Indian J. Clin. Biochem. 25(1): 86-91.
18. Suer C, Dolu N, Artis AS, Sahin L, Aydogan S (2011). Electrophysiological evidence of biphasic action of carnosine on longterm potentiation in urethane-anesthetized rats. Neuropeptides, 45(1): 77-81.
19. Zhang JG, Lindup WE (1996). Role of Calcium in CP-induced cell toxicity in rat renal cortical slices. Toxicol. vitro, 10(2): 205-209.